Swiss Roche’s Immunotherapy Tecentriq Fails Clinical Trial Swiss Roche’s Immunotherapy Tecentriq Fails Clinical Trial By Leslie Allen on January 25, 2020 Roche’s Tecentriq failed a late-stage clinical trial in the form of urothelial cancer, the Swiss drug manufacturer stated Friday. The study assessing Tecentriq as an…